Heidelberg Engineering
German ophthalmic imaging specialist. Primary global competitor to Carl Zeiss Meditec in retinal OCT, with a separate strong franchise in confocal scanning-laser ophthalmoscopy. Privately held; research-grade reputation for optical quality, eye-tracking, and image data integrity. Strongest in academic and research-heavy practices, with growing presence in commercial retinal and glaucoma clinics.
Company history
- 1990 — founded in Heidelberg by Gerhard Zinser, Christoph Schäfer, and Kfir Azoulay.
- 1990s — Heidelberg Retina Angiograph (HRA) introduces clinical confocal scanning-laser ophthalmoscopy (cSLO).
- Early 2000s — Heidelberg Retina Tomograph (HRT) for glaucoma imaging.
- 2007 — Spectralis launches — combining cSLO + spectral-domain OCT in one device with eye-tracked acquisition. Establishes Heidelberg as a top-tier OCT vendor.
- 2010s–2020s — Spectralis expansion: OCT angiography (OCT-A), widefield modules (Heidelberg HRA + Spectralis with widefield lens), MultiColor imaging, anterior-segment OCT, MicroPerimeter integration. Heidelberg's HEYEX 2 software ecosystem becomes a research-and-clinic data platform.
Product line
- Spectralis family — cSLO + OCT + OCT-A + widefield modular platform. Customers configure base unit plus modality modules (HRA, BluePeak autofluorescence, OCT2, OCT-A).
- HRT3 — Heidelberg Retina Tomograph for confocal scanning-laser glaucoma imaging; legacy but still installed in many academic clinics.
- ANTERION — swept-source anterior-segment OCT and biometry for cataract / refractive workflows.
Distinctive technology
- cSLO + OCT hybrid acquisition — where Zeiss Cirrus is pure OCT, Spectralis combines confocal scanning-laser ophthalmoscopy with OCT in one acquisition, providing a high-contrast fundus image registered to the OCT cross-section.
- TruTrack active eye tracking — real-time compensation during OCT acquisition; meaningfully improves image stability in older / uncooperative / nystagmus patients and enables follow-up scans on identical retinal locations.
- OCT-A (angiography) — dye-free vascular imaging at clinical quality.
- HEYEX 2 software platform — DICOM export hygiene, research-data export, and integration with third-party platforms is a Heidelberg differentiator.
- MultiColor imaging — three-laser cSLO at distinct wavelengths for layer-specific retinal contrast.
Market position
Strong #2 globally in retinal OCT after Zeiss. Preferred in academic and research-heavy practices where image quality, eye-tracking, and data export matter more than throughput. Zeiss Cirrus is more commonly deployed in high-volume general ophthalmology. Topcon holds significant Asia-Pacific share. Optovue (Visionix) and Nidek round out the global category. Glaucoma-imaging market is more fragmented but HRT and Spectralis Glaucoma Module retain strong academic preference.
Refurb posture
- Spectralis modular configuration is the price-determining variable on refurbs — a base Spectralis without OCT-A or widefield modules is meaningfully different from a fully-configured unit.
- HEYEX software version + license tier — analytics packages and normative databases are version-locked.
- Vendor lock-in on patient longitudinal records — same dynamic as Zeiss; Heidelberg-to-Heidelberg refurbs preserve clinic data continuity.
- Older HRA / HRT-2 / HRT-3 units appear in academic-clinic turnover; service-network reach for legacy hardware is a refurb consideration.